Menzies Research Seminars are returning for 2023! We’re looking forward to bringing you the latest research on a range of topics, spanning tropical diseases and Indigenous health.
We’re starting with a lunchtime presentation from our Malaria team in our Global and Tropical Health Division.
Menzies Senior Research Fellow, Dr Rob Commons will provide an update on: What dose of primaquine is best to prevent relapsing vivax malaria?
If you have an interest in malaria and tropical diseases, we hope to see you at this research seminar.
Event Details:
When | Wednesday 15 February 2023, 12 noon – 12.30pm (ACST)
Where | JMB Auditorium, Menzies School of Health Research, Building 58, Royal Darwin Hospital Campus, Corner of Nightingale and Paracelsus road, Tiwi.
Online attendance via Zoom is also available (link provided with registration).
Cost | This is a free event.
Registration | Registration is essential for both in person and online attendance.
Please register for a ticket via the Sticky Tickets platform. Either click the image or the link below to register.
Register: https://www.stickytickets.com.au/FK9MT
Dr Rob Commons:
Dr Rob Commons is an Infectious Diseases Physician in Ballarat, Victoria and a Senior Research Fellow at Menzies.
His PhD, which he completed in 2019, investigated primaquine as a radical cure for Plasmodium vivax malaria in collaboration with World-Wide Antimalarial Resistance Network (WWARN). He was supervised by Menzies researchers, Professor Ric Price and Dr Kamala Thriemer and Professor Julie Simpson from The University of Melbourne. He continues to research ways to improve vivax radical cure, including undertaking large pooled individual patient data meta-analyses with WWARN to examine the efficacy and safety of different primaquine doses.